Literature DB >> 34629717

Extrahepatic Applications of Yttrium-90 Radioembolization.

Nikitha Murali1, Samdeep K Mouli1, Ahsun Riaz1, Robert J Lewandowski1, Riad Salem1.   

Abstract

While initially described and now accepted as treatment for primary and secondary malignancies in the liver, radioembolization therapy has expanded to include treatment for other disease pathologies and other organ systems. Advantages and limitations for these treatments exist and must be compared against more traditional treatments for these processes. This article provides an overview of the current applications for radioembolization outside of the liver, for both malignant and nonmalignant disease. Thieme. All rights reserved.

Entities:  

Keywords:  extrahepatic; interventional radiology; radioembolization; radiotherapy; yttrium-90

Year:  2021        PMID: 34629717      PMCID: PMC8497088          DOI: 10.1055/s-0041-1735573

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.780


  19 in total

1.  TREATMENT OF INOPERABLE PRIMARY PANCREATIC AND LIVER CANCER BY THE INTRA-ARTERIAL ADMINISTRATION OF RADIOACTIVE ISOTOPES (Y90 RADIATING MICROSPHERES).

Authors:  I M ARIEL
Journal:  Ann Surg       Date:  1965-08       Impact factor: 12.969

2.  Radioembolization of renal cell carcinoma using yttrium-90 microspheres.

Authors:  Nabeel Hamoui; Vanessa L Gates; Jose Gonzalez; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-01-28       Impact factor: 3.464

3.  Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.

Authors:  B Gray; G Van Hazel; M Hope; M Burton; P Moroz; J Anderson; V Gebski
Journal:  Ann Oncol       Date:  2001-12       Impact factor: 32.976

4.  Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients.

Authors:  João M Pisco; Tiago Bilhim; Luis C Pinheiro; Lucia Fernandes; Jose Pereira; Nuno V Costa; Marisa Duarte; António G Oliveira
Journal:  J Vasc Interv Radiol       Date:  2016-06-16       Impact factor: 3.464

5.  Effects of hepatic arterial yttrium 90 glass microspheres in dogs.

Authors:  I Wollner; C Knutsen; P Smith; D Prieskorn; C Chrisp; J Andrews; J Juni; S Warber; J Klevering; J Crudup
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

6.  Yttrium-90 Radioembolization to the Prostate Gland: Proof of Concept in a Canine Model and Clinical Translation.

Authors:  Samdeep K Mouli; Simone Raiter; Kathleen Harris; Amrutha Mylarapu; Malcolm Burks; Weiguo Li; Andrew C Gordon; Ali Khan; Monica Matsumoto; Keith L Bailey; Alexander S Pasciak; Sasicha Manupipatpong; Clifford R Weiss; David Casalino; Frank H Miller; Vanessa L Gates; Elias Hohlastos; Robert J Lewandowski; Dong-Hyun Kim; Matthew R Dreher; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2021-04-09       Impact factor: 3.464

7.  Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.

Authors:  Ron C Gaba; Robert J Lewandowski; Laura M Kulik; Ahsun Riaz; Saad M Ibrahim; Mary F Mulcahy; Robert K Ryu; Kent T Sato; Vanessa Gates; Michael M Abecassis; Reed A Omary; Talia B Baker; Riad Salem
Journal:  Ann Surg Oncol       Date:  2009-04-09       Impact factor: 5.344

8.  Role of Locoregional Therapy and Predictors for Dropout in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.

Authors:  Rahul A Sheth; Madhukar S Patel; Brian Koottappillil; Jigesh A Shah; Rahmi Oklu; Peter Mueller; Parsia A Vagefi; Suvranu Ganguli
Journal:  J Vasc Interv Radiol       Date:  2015-09-26       Impact factor: 3.464

9.  Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.

Authors:  Riad Salem; Robert Lewandowski; Carol Roberts; James Goin; Kenneth Thurston; Marwan Abouljoud; Angi Courtney
Journal:  J Vasc Interv Radiol       Date:  2004-04       Impact factor: 3.464

Review 10.  History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.

Authors:  Aman Saini; Alex Wallace; Sadeer Alzubaidi; M Grace Knuttinen; Sailendra Naidu; Rahul Sheth; Hassan Albadawi; Rahmi Oklu
Journal:  J Clin Med       Date:  2019-01-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.